Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleExperimental Studies

Experimental Models for Therapeutic Studies of Transitional Cell Carcinoma

UTE GABRIEL, CHRISTIAN BOLENZ and MAURICE STEPHAN MICHEL
Anticancer Research September 2007, 27 (5A) 3163-3171;
UTE GABRIEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ute.gabriel@uro.ma.uni-heidelberg.de
CHRISTIAN BOLENZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAURICE STEPHAN MICHEL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Transitional cell carcinoma (TCC) is the second most common malignancy of the genito-urinary tract. To date, the therapy options available seem unable to prevent TCC recurrence and its progression, even though therapy studies are constantly investigating new treatment options. A great variety of TCC models have been described. For each study, the model has to be modified according to the specific investigative aim. The establishment of reproducible models is a continuing challenge. Currently, there is a strong tendency towards 3-dimensional models for in vitro studies. The aim of this article was to review current ex vivo and in vivo models used in studies of TCC therapy. We describe 2- and 3-dimensional cell and tissue cultures, as well as the set-up, investigative options and detection methods used in rodent heterotopic and orthotopic models.

  • Transitional cell carcinoma
  • bladder cancer
  • experimental model
  • in vitro
  • in vivo
  • experimental therapy
  • review

Footnotes

  • Received May 10, 2007.
  • Revision received July 5, 2007.
  • Accepted July 26, 2007.
  • Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research: 27 (5A)
Anticancer Research
Vol. 27, Issue 5A
September-October 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Experimental Models for Therapeutic Studies of Transitional Cell Carcinoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 9 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Experimental Models for Therapeutic Studies of Transitional Cell Carcinoma
UTE GABRIEL, CHRISTIAN BOLENZ, MAURICE STEPHAN MICHEL
Anticancer Research Sep 2007, 27 (5A) 3163-3171;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Experimental Models for Therapeutic Studies of Transitional Cell Carcinoma
UTE GABRIEL, CHRISTIAN BOLENZ, MAURICE STEPHAN MICHEL
Anticancer Research Sep 2007, 27 (5A) 3163-3171;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer
  • In Vitro and In Vivo Experimental Models as Tools to Investigate the Efficacy of Antineoplastic Drugs on Urinary Bladder Cancer
  • Exploring molecular genetics of bladder cancer: lessons learned from mouse models
  • Google Scholar

More in this TOC Section

  • Role of Platelet Interactions in Promoting Melanoma Malignancy With Insights into Proliferation, Cyclin D1 Expression, and Migration
  • Recombinant Methioninase and Cisplatinum Act Synergistically to Inhibit Lewis Lung Carcinoma Cells But Not Normal Fibroblasts
  • Light Bladder Net: Non-invasive Bladder Cancer Prediction by Weighted Deep Learning Approaches and Graphical Data Transformation
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire